Clara reads your A1C, eGFR, and full medication list against the Ozempic label before anything is drafted. Free to connect your records.
Get started How it worksClara auto-syncs your chart from 150,000+ doctors' offices, hospitals, clinics, labs, and wearables. Before Ozempic is drafted, the AI reads your A1C history, fasting glucose, kidney function, lipid panel, thyroid family history, pancreatitis history, and full medication list against the Ozempic label. Free to start.
If Ozempic is clinically appropriate, a licensed physician reviews Clara's plan and signs the prescription. It's sent to your pharmacy as branded FDA-approved Ozempic and may be covered by your insurance, unlike the cash-pay GLP-1 model most DTC telehealth brands run.
Ozempic starts at 0.25 mg weekly for 4 weeks, then 0.5 mg; dose may be increased to 1 mg and up to 2 mg weekly for additional glycemic control1. Clara tracks A1C every 3 months, watches GI tolerability, flags interactions with any new medication, and reorders labs on cadence.
Connect your chart and see what Clara thinks before a script is even drafted.
Get started Free to connect your records. No credit card to start.Once-weekly injection. FDA-approved to improve glycemic control in adults with type 2 diabetes and to reduce CV risk in T2D adults with established CV disease. A1C reductions studied at 0.5, 1, and 2 mg doses; 2 mg available for additional glycemic control1.
Oral biguinide. Standard first-line agent for type 2 diabetes and inexpensive on most insurance formularies. Clara typically confirms metformin is in place (and tolerated) before adding or switching to a GLP-1, per ADA Standards of Care.
Once-weekly dual GIP/GLP-1 agonist, also on-label for type 2 diabetes. In head-to-head and cross-trial data, tirzepatide produces larger A1C and weight reductions than semaglutide; it's Clara's usual next step when Ozempic is tolerated but under-effective at the 2 mg dose3.
If your primary goal is weight management and you don't have type 2 diabetes, Ozempic is off-label. The on-label alternatives are Wegovy (same semaglutide molecule, dosed to 2.4 mg for chronic weight management) and Zepbound (tirzepatide, weight-management label). Clara routes you there based on BMI and comorbidity.
| Clara | Hims & Hers | Lemonaid Health | Your doctor | |
|---|---|---|---|---|
| 24/7 AI clinical chat | ✓ Unlimited | Async Care Team messaging | Async provider messaging | ✗ |
| Checks Ozempic label against your full chart (A1C, eGFR, MTC family history, pancreatitis, retinopathy, pregnancy) | ✓ Every prescription | Weight-loss intake only | Per-category intake | Depends on visit length |
| Cost to start | Free | $39 first-month membership | Brief eligibility assessment | $150+ copay per visit |
| Membership cost | From $25/mo cash-pay (HSA/FSA eligible); medication billed separately, may be covered by your insurance | $149/mo after first month; medication bundled, cash-pay | $49/mo; medication billed separately, cash-pay | Per-visit copay |
| Branded FDA-approved Ozempic | ✓ | Ozempic from $199/mo cash on top of membership | Sold alongside compounded semaglutide, cash-pay | ✓ |
| Ozempic prescription may be covered by your insurance | ✓ | ✗ Cash-pay model | ✗ Cash-pay model | ✓ |
| On-label routing (T2D vs. weight management) | ✓ Reads A1C, BMI, comorbidities | Weight-loss intake | Weight-loss intake | Depends on clinician |
| Cross-condition reasoning (BP, thyroid, lipids, kidney) | ✓ | Single-condition | Per-intake siloes | In theory, rarely in 15 minutes |
| Full primary care, not just GLP-1s | ✓ | Single-category | Partial, separate intakes | ✓ |
Most GLP-1 telehealth sells compounded semaglutide. Clara sends branded FDA-approved Ozempic.
Get started Your prescription may be covered by your insurance. HSA/FSA eligible.Ozempic is the right drug for some patients, the wrong drug for others, and a dangerous drug for a small set. Sorting that out cleanly requires reading labs, family history, pregnancy plans, medication list, and trend data together. It's the kind of pattern-finding work a 15-minute visit can't do, no matter how good the physician.
Clara cross-references 18 months of A1C values against fasting glucose, weight trend, lipid panel, eGFR, home BP, and wearable resting HR in one pass. A human clinician can realistically eyeball the last two or three panels in a quarterly visit. Holding thousands of datapoints in working memory is a category of work a physician can't do, regardless of time or training.
Before Ozempic is drafted, Clara runs the interaction matrix against your full medication list, screens for personal or family history of medullary thyroid carcinoma and MEN 2 (both contraindications)1, checks for prior pancreatitis, diabetic retinopathy status, eGFR trend, and active pregnancy plans. Any red flag, and Clara routes you to a safer alternative instead of pushing the Rx.
Clara can cite the specific SUSTAIN-6 CV outcome table, the Section 14.1 A1C numbers at 1 mg and 2 mg, or the SUSTAIN FORTE data behind any Ozempic dose recommendation. A generalist physician likely last read the primary literature on semaglutide years ago, if at all.
The same AI reads the Ozempic label, every trial, and your complete chart in one pass.
Get started 150,000+ sources synced automatically. Cancel anytime.Start free. Connect your records. See what happens when an AI reads the Ozempic label against your whole chart.
Get started